CC
Claybrook Capital’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $355K | Buy |
10,705
+205
| +2% | +$6.8K | 0.2% | 103 |
|
|
2023
Q2 | $385K | Hold |
10,500
| – | – | 0.21% | 100 |
|
|
2023
Q1 | $428K | Hold |
10,500
| – | – | 0.24% | 93 |
|
|
2022
Q4 | $538K | Sell |
10,500
-4,135
| -28% | -$212K | 0.33% | 74 |
|
|
2022
Q3 | $640K | Hold |
14,635
| – | – | 0.41% | 71 |
|
|
2022
Q2 | $767K | Sell |
14,635
-50
| -0.3% | -$2.62K | 0.45% | 66 |
|
|
2022
Q1 | $760K | Sell |
14,685
-75
| -0.5% | -$3.88K | 0.38% | 73 |
|
|
2021
Q4 | $872K | Buy |
14,760
+75
| +0.5% | +$4.43K | 0.41% | 69 |
|
|
2021
Q3 | $632K | Sell |
14,685
-83,961
| -85% | -$3.61M | 0.32% | 81 |
|
|
2021
Q2 | $3.86M | Buy |
98,646
+52,961
| +116% | +$2.07M | 1.26% | 21 |
|
|
2021
Q1 | $1.66M | Hold |
45,685
| – | – | 0.96% | 36 |
|
|
2020
Q4 | $1.68M | Buy |
45,685
+50
| +0.1% | +$1.84K | 1.11% | 35 |
|
|
2020
Q3 | $1.68M | Buy |
45,635
+1,500
| +3% | +$55.1K | 1.26% | 26 |
|
|
2020
Q2 | $1.44M | Buy |
+44,135
| New | +$1.44M | 1.24% | 25 |
|
|
2019
Q1 | – | Sell |
-3,790
| Closed | -$165K | – | 514 |
|
|
2018
Q4 | $165K | Sell |
3,790
-322
| -8% | -$14K | 0.05% | 150 |
|
|
2018
Q3 | $181K | Hold |
4,112
| – | – | 0.11% | 80 |
|
|
2018
Q2 | $149K | Hold |
4,112
| – | – | 0.09% | 80 |
|
|
2018
Q1 | $146K | Sell |
4,112
-853
| -17% | -$30.3K | 0.1% | 80 |
|
|
2017
Q4 | $180K | Buy |
+4,965
| New | +$180K | 0.13% | 83 |
|